Abstract
Bioelectrical impedance for measurement of total body fat and computed tomography for visceral and subcutaneous fat at umbilicus levels were performed in 34 obese and 10 lean men. Insulin secretion in response to an oral glucose tolerance test (OGTT) and a GH stimulation test by L-dopa, growth hormone-binding protein (GHBP) and IGF-I were measured. Obese subjects were divided into three groups according to the OGTT. The obese type II diabetes mellitus group had the highest GHBP levels and the most visceral fat. GHBP levels were most strongly correlated with the ratio of visceral fat area to body weight (VWR) above any other parameters (r = 0.725, P < 0.001). The insulin and free fatty acid (FFA) areas under curves (AUC) during the OGTT, and the IGF-I level, were also positively correlated with GHBP levels (r=0.474, P<0.005; r=0.572, P<0.005; r=0.453, P<0.005). GH-AUC to the L-dopa stimulation test was negatively correlated with GHBP levels (r=-0.432, P < 0.005). Stepwise multiple linear regression analysis showed that VWR, FFA- AUC and insulin-AUC significantly contributed to the variability of GHBP (r2= 0.58). In conclusion, we demonstrated that: (i) visceral fat amount mainly determined GHBP levels in obese men with varying glucose tolerance; (ii) hyperglycemia per se did not influence the GHBP level, whereas insulin and FFA could play a role in regulation of GHBP; and (iii) although GH was not the main regulator of GHBP, the unchanged IGF-I level despite GH hyposecretion suggests that increased GHBP levels reflect GH hypersensitivity in order to compensate for decreased GH secretion in obesity.
| Original language | English |
|---|---|
| Pages (from-to) | 159-163 |
| Number of pages | 5 |
| Journal | European Journal of Endocrinology |
| Volume | 140 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 1999 Feb 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Endocrinology, Diabetes and Metabolism
- Endocrinology
Cite this
}
GH-binding protein in obese men with varying glucose tolerance : Relationship to body fat distribution, insulin secretion and the GH-IGF-I axis. / Nam, Su Youn; Kim, Kyung Rae; Song, Young Duk; Lim, Sungkil; Lee, Hyun Chul; Huh, Kap Bum.
In: European Journal of Endocrinology, Vol. 140, No. 2, 01.02.1999, p. 159-163.Research output: Contribution to journal › Article
TY - JOUR
T1 - GH-binding protein in obese men with varying glucose tolerance
T2 - Relationship to body fat distribution, insulin secretion and the GH-IGF-I axis
AU - Nam, Su Youn
AU - Kim, Kyung Rae
AU - Song, Young Duk
AU - Lim, Sungkil
AU - Lee, Hyun Chul
AU - Huh, Kap Bum
PY - 1999/2/1
Y1 - 1999/2/1
N2 - Bioelectrical impedance for measurement of total body fat and computed tomography for visceral and subcutaneous fat at umbilicus levels were performed in 34 obese and 10 lean men. Insulin secretion in response to an oral glucose tolerance test (OGTT) and a GH stimulation test by L-dopa, growth hormone-binding protein (GHBP) and IGF-I were measured. Obese subjects were divided into three groups according to the OGTT. The obese type II diabetes mellitus group had the highest GHBP levels and the most visceral fat. GHBP levels were most strongly correlated with the ratio of visceral fat area to body weight (VWR) above any other parameters (r = 0.725, P < 0.001). The insulin and free fatty acid (FFA) areas under curves (AUC) during the OGTT, and the IGF-I level, were also positively correlated with GHBP levels (r=0.474, P<0.005; r=0.572, P<0.005; r=0.453, P<0.005). GH-AUC to the L-dopa stimulation test was negatively correlated with GHBP levels (r=-0.432, P < 0.005). Stepwise multiple linear regression analysis showed that VWR, FFA- AUC and insulin-AUC significantly contributed to the variability of GHBP (r2= 0.58). In conclusion, we demonstrated that: (i) visceral fat amount mainly determined GHBP levels in obese men with varying glucose tolerance; (ii) hyperglycemia per se did not influence the GHBP level, whereas insulin and FFA could play a role in regulation of GHBP; and (iii) although GH was not the main regulator of GHBP, the unchanged IGF-I level despite GH hyposecretion suggests that increased GHBP levels reflect GH hypersensitivity in order to compensate for decreased GH secretion in obesity.
AB - Bioelectrical impedance for measurement of total body fat and computed tomography for visceral and subcutaneous fat at umbilicus levels were performed in 34 obese and 10 lean men. Insulin secretion in response to an oral glucose tolerance test (OGTT) and a GH stimulation test by L-dopa, growth hormone-binding protein (GHBP) and IGF-I were measured. Obese subjects were divided into three groups according to the OGTT. The obese type II diabetes mellitus group had the highest GHBP levels and the most visceral fat. GHBP levels were most strongly correlated with the ratio of visceral fat area to body weight (VWR) above any other parameters (r = 0.725, P < 0.001). The insulin and free fatty acid (FFA) areas under curves (AUC) during the OGTT, and the IGF-I level, were also positively correlated with GHBP levels (r=0.474, P<0.005; r=0.572, P<0.005; r=0.453, P<0.005). GH-AUC to the L-dopa stimulation test was negatively correlated with GHBP levels (r=-0.432, P < 0.005). Stepwise multiple linear regression analysis showed that VWR, FFA- AUC and insulin-AUC significantly contributed to the variability of GHBP (r2= 0.58). In conclusion, we demonstrated that: (i) visceral fat amount mainly determined GHBP levels in obese men with varying glucose tolerance; (ii) hyperglycemia per se did not influence the GHBP level, whereas insulin and FFA could play a role in regulation of GHBP; and (iii) although GH was not the main regulator of GHBP, the unchanged IGF-I level despite GH hyposecretion suggests that increased GHBP levels reflect GH hypersensitivity in order to compensate for decreased GH secretion in obesity.
UR - http://www.scopus.com/inward/record.url?scp=0345040221&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0345040221&partnerID=8YFLogxK
U2 - 10.1530/eje.0.1400159
DO - 10.1530/eje.0.1400159
M3 - Article
VL - 140
SP - 159
EP - 163
JO - European Journal of Endocrinology
JF - European Journal of Endocrinology
SN - 0804-4643
IS - 2
ER -